Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17932908

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2007 Dec 1
First author
Negrier S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2007 Dec 1;110(11):2366-9. doi: 10.1002/cncr.23053.
    note
    Source null
    related pmid
    17941002
    relationship
    Comment in

Authors and identifiers

  1. name
    Negrier S
    type
    Author
  2. name
    Perol D
    type
    Author
  3. name
    Ravaud A
    type
    Author
  4. name
    Chevreau C
    type
    Author
  5. name
    Bay JO
    type
    Author
  6. name
    Delva R
    type
    Author
  7. name
    Sevin E
    type
    Author
  8. name
    Caty A
    type
    Author
  9. name
    Escudier B
    type
    Author
  10. name
    French Immunotherapy Intergroup
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Negrier S
    type
    Author
  2. name
    Perol D
    type
    Author
  3. name
    Ravaud A
    type
    Author
  4. name
    Chevreau C
    type
    Author
  5. name
    Bay JO
    type
    Author
  6. name
    Delva R
    type
    Author
  7. name
    Sevin E
    type
    Author
  8. name
    Caty A
    type
    Author
  9. name
    Escudier B
    type
    Author
  10. name
    French Immunotherapy Intergroup
    type
    CollectiveName
bibliography ids
  1. nci-bib-2cebcf4c6c188eb4e3fc4fa8
book metadata
content sha256
3bb2e12400f2ce5d9143d8a010b9bc0156d6cb5165279019ec2ca5429c66b26c
document type
citation
dois
  1. 10.1002/cncr.23056
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17932908
immutable id
pubmed:17932908@3bb2e12400f2ce5d9143d8a010b9bc0156d6cb5165279019ec2ca5429c66b26c
journal
abbreviation
Cancer
issn electronic
Source null
issn print
0008-543X
issue
11
name
Cancer
nlm unique id
0374236
pages
2468-77
volume
110
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2007 Dec 1;110(11):2366-9. doi: 10.1002/cncr.23053.
    note
    Source null
    related pmid
    17941002
    relationship
    Comment in
outcomes validated
false
pmid
17932908
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
7b606513caf4f2cc36f857661c05b50a118dcd5191af9249c0b87a8a0d84c86f
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2007 Dec 1
precision
day
year
2007
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17932908/
title
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.

Preserved source evidence · Not medical advice